BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,336,000 | -22.6% | 45,000 | -10.0% | 0.65% | -7.7% |
| Q4 2021 | $6,891,000 | -0.8% | 50,000 | 0.0% | 0.70% | -7.7% |
| Q3 2021 | $6,946,000 | +43.1% | 50,000 | 0.0% | 0.76% | +40.4% |
| Q2 2021 | $4,854,000 | +42.0% | 50,000 | 0.0% | 0.54% | +29.5% |
| Q1 2021 | $3,418,000 | -11.4% | 50,000 | +11.1% | 0.42% | -27.2% |
| Q4 2020 | $3,857,000 | +48.3% | 45,000 | +12.5% | 0.57% | +16.0% |
| Q3 2020 | $2,600,000 | -11.1% | 40,000 | 0.0% | 0.49% | -18.5% |
| Q2 2020 | $2,924,000 | +114.8% | 40,000 | 0.0% | 0.61% | +67.9% |
| Q1 2020 | $1,361,000 | -37.5% | 40,000 | 0.0% | 0.36% | -17.0% |
| Q4 2019 | $2,178,000 | +30.5% | 40,000 | 0.0% | 0.44% | +18.5% |
| Q3 2019 | $1,669,000 | +90.5% | 40,000 | +100.0% | 0.37% | +99.5% |
| Q2 2019 | $876,000 | – | 20,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |